Papers
5
Total Citations
54
H-Index
5
About
Francesco Chiari is a leading surgical oncologist whose research centers on advancing transoral robotic surgery (TORS) for head and neck cancers, particularly oropharyngeal and supraglottic squamous cell carcinoma. His major contributions include comprehensive systematic reviews that establish TORS as a minimally invasive alternative to open surgery, demonstrating superior functional preservation of speech and swallowing while reducing morbidity. In his landmark 2024 study (22 citations), Chiari systematically evaluated functional outcomes after TORS for oropharyngeal cancer, providing critical evidence for its role in organ-preserving treatment. His 2024 review comparing TORS to open supraglottic surgery (13 citations) further solidified the technique’s oncologic and functional advantages. Chiari has also pioneered applications for benign and malignant parapharyngeal space tumors, as shown in his 2025 comparative analysis (6 citations). His work on temporary tracheotomy predictors (8 citations) offers practical guidance for perioperative management. With over 50 citations across his most-cited papers, Chiari’s research is shaping modern head and neck oncology by validating robotic approaches that improve quality of life without compromising cancer control—a vital contribution for surgeons and patients alike.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5